CD274 and neoplasm: The analyses reported here explores interobserver reliability of tumor expression of PD-L1 and identifies optimal cutpoints for tumor expression of PD-L1 and whether it is a prognostic biomarker for clinical outcomes of women participating in the PHAEDRA study.